China Klebsiella Pneumoniae Infection Drug Market Research Report 2018

February 2018 | 112 pages | ID: C7D0B006EF7QEN
QYResearch

Abstracts

The global Klebsiella Pneumoniae Infection Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Klebsiella Pneumoniae Infection Drug development status and future trend in China, focuses on top players in China, also splits Klebsiella Pneumoniae Infection Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Acies Bio doo
• Appili Therapeutics
• Debiopharm International SA
• Evaxion Biotech ApS
• F. Hoffmann-La Roche Ltd
• FOB Synthesis Inc
• ImmunoClin Corp
• Innovation Pharmaceuticals Inc
• Kyorin Pharmaceutical Co Ltd
• Melinta Therapeutics Inc
• Nosopharm SAS
• Peptilogics Inc
• Pfizer Inc
• Phico Therapeutics Ltd
• Sarepta Therapeutics Inc
• Shionogi & Co Ltd
• Syntiron LLC
• Tetraphase Pharmaceuticals Inc

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• ATI-1503
• CA-824
• CC-1807
• Cefiderocol
• Debio-1454
• EBX-004
• Others

On the basis of the end users/application, this report covers

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Klebsiella Pneumoniae Infection Drug Market Research Report 2017

1 KLEBSIELLA PNEUMONIAE INFECTION DRUG OVERVIEW

1.1 Product Overview and Scope of Klebsiella Pneumoniae Infection Drug
1.2 Classification of Klebsiella Pneumoniae Infection Drug by Product Category
  1.2.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Comparison by Type (2012-2022)
  1.2.2 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Market Share by Type in 2016
  1.2.3 ATI-1503
  1.2.4 CA-824
  1.2.5 CC-1807
  1.2.6 Cefiderocol
  1.2.7 Debio-1454
  1.2.8 EBX-004
  1.2.9 Others
1.3 China Klebsiella Pneumoniae Infection Drug Market by Application/End Users
  1.3.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 China Klebsiella Pneumoniae Infection Drug Market by Region
  1.4.1 China Klebsiella Pneumoniae Infection Drug Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)
  1.4.3 East China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)
  1.4.4 Southwest China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)
  1.4.5 Northeast China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)
  1.4.6 North China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)
  1.4.7 Central China Klebsiella Pneumoniae Infection Drug Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Klebsiella Pneumoniae Infection Drug (2012-2022)
  1.5.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)
  1.5.2 China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Klebsiella Pneumoniae Infection Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Klebsiella Pneumoniae Infection Drug Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Klebsiella Pneumoniae Infection Drug Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Klebsiella Pneumoniae Infection Drug Market Competitive Situation and Trends
  2.4.1 China Klebsiella Pneumoniae Infection Drug Market Concentration Rate
  2.4.2 China Klebsiella Pneumoniae Infection Drug Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA KLEBSIELLA PNEUMONIAE INFECTION DRUG SALES AND REVENUE BY REGION (2012-2017)

3.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Regions (2012-2017)

4 CHINA KLEBSIELLA PNEUMONIAE INFECTION DRUG SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2012-2017)
4.4 China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Type (2012-2017)

5 CHINA KLEBSIELLA PNEUMONIAE INFECTION DRUG SALES BY APPLICATION (2012-2017)

5.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA KLEBSIELLA PNEUMONIAE INFECTION DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Acies Bio doo
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Appili Therapeutics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Debiopharm International SA
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Evaxion Biotech ApS
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 FOB Synthesis Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 ImmunoClin Corp
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Innovation Pharmaceuticals Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Kyorin Pharmaceutical Co Ltd
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Melinta Therapeutics Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Nosopharm SAS
6.12 Peptilogics Inc
6.13 Pfizer Inc
6.14 Phico Therapeutics Ltd
6.15 Sarepta Therapeutics Inc
6.16 Shionogi & Co Ltd
6.17 Syntiron LLC
6.18 Tetraphase Pharmaceuticals Inc

7 KLEBSIELLA PNEUMONIAE INFECTION DRUG MANUFACTURING COST ANALYSIS

7.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.


List of Tables and Figures

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Klebsiella Pneumoniae Infection Drug
Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Types in 2016
Figure ATI-1503 Product Picture
Figure CA-824 Product Picture
Figure CC-1807 Product Picture
Figure Cefiderocol Product Picture
Figure Debio-1454 Product Picture
Figure EBX-004 Product Picture
Figure Others Product Picture
Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Klebsiella Pneumoniae Infection Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Klebsiella Pneumoniae Infection Drug Sales of Key Players/Manufacturers (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players/Manufacturers
Table China Klebsiella Pneumoniae Infection Drug Revenue by Players/Manufacturers (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Klebsiella Pneumoniae Infection Drug Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Klebsiella Pneumoniae Infection Drug Average Price of Key Players/Manufacturers in 2016
Figure China Klebsiella Pneumoniae Infection Drug Market Share of Top 3 Players/Manufacturers
Figure China Klebsiella Pneumoniae Infection Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Klebsiella Pneumoniae Infection Drug Product Category
Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Regions (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Regions (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Regions (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Regions in 2016
Table China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions in 2016
Table China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Regions (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Type (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Share (%) by Type (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Type in 2016
Table China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Klebsiella Pneumoniae Infection Drug by Type (2012-2017)
Figure Revenue Market Share of Klebsiella Pneumoniae Infection Drug by Type in 2016
Table China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Types (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Type (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Applications (2012-2017)
Table China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Applications (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application in 2016
Table China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Application (2012-2017)
Figure China Klebsiella Pneumoniae Infection Drug Sales Growth Rate (%) by Application (2012-2017)
Table Acies Bio doo Klebsiella Pneumoniae Infection Drug Basic Information List
Table Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table Appili Therapeutics Klebsiella Pneumoniae Infection Drug Basic Information List
Table Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table Debiopharm International SA Klebsiella Pneumoniae Infection Drug Basic Information List
Table Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Basic Information List
Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Basic Information List
Table ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in China (2012-2017)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in China (2012-2017)
Table Nosopharm SAS Klebsiella Pneumoniae Infection Drug Basic Information List
Table Peptilogics Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Pfizer Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Basic Information List
Table Syntiron LLC Klebsiella Pneumoniae Infection Drug Basic Information List
Table Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Klebsiella Pneumoniae Infection Drug
Figure Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
Figure Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
Table Raw Materials Sources of Klebsiella Pneumoniae Infection Drug Major Players/Manufacturers in 2016
Table Major Buyers of Klebsiella Pneumoniae Infection Drug
Table Distributors/Traders List
Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Type in 2022
Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Application in 2022
Table China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Klebsiella Pneumoniae Infection Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Klebsiella Pneumoniae Infection Drug Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources